AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 273: H1727-H1736, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Øie, E.
Right arrow Articles by Attramadal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Øie, E.
Right arrow Articles by Attramadal, H.
Vol. 273, Issue 4, H1727-H1736, October 1997

Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats

Erik Øie1, Leif Erik Vinge1, Theis Tønnessen2, Haakon Kiil Grøgaard1, Harald Kjekshus1, Geir Christensen2, Otto A. Smiseth1, and Håvard Attramadal1

1 Institute for Surgical Research, The National Hospital, and 2 Institute for Experimental Medical Research, Ullevål Hospital, University of Oslo, N-0027 Oslo, Norway

Increased myocardial expression of preproendothelin-1 (ppET-1) mRNA has been associated with congestive heart failure (CHF) in rats. However, the time course and isoform pattern of ppET mRNA induction and the cellular localization of ET in failing hearts are unknown. Thus our aim was to investigate myocardial ppET mRNA expression in CHF rats during the first 6 wk after induction of myocardial infarction. Furthermore, performing immunohistochemical analysis, we also investigated the origin and localization of immunoreactive endothelin (ET) in different regions of the failing heart. Ribonuclease protection assays revealed a marked increase in ppET-1 mRNA levels in rat myocardial tissues during CHF. The induction of ppET-1 mRNA was isopeptide specific and transient. The most substantial upregulation was observed in the infarcted area, where maximal expression of ppET-1 mRNA was observed after 7 days (25-fold increase, P < 0.05). However, a marked and statistically significant induction of ppET-1 mRNA was also observed in the nonischemic myocardium. Immunohistochemical analysis revealed ET-1-like immunoreactivity in cardiomyocytes, vascular endothelial cells, macrophages, and proliferating fibroblasts. Thus immunohistochemistry revealed the structural basis for the dramatic upregulation of the myocardial ET system in the infarcted region, suggesting a role for ET in the healing process after myocardial infarction. However, the global upregulation of ppET-1 mRNA in the heart also suggests an autocrine/paracrine regulatory mechanism in the nonischemic myocardium during CHF.

autocrine/paracrine; gene expression; immunohistochemistry; ischemia


This article has been cited by other articles:


Home page
Eur Heart JHome page
A. Yndestad, L. Landro, T. Ueland, C. P. Dahl, T. H. Flo, L. E. Vinge, T. Espevik, S. S. Froland, C. Husberg, G. Christensen, et al.
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur. Heart J., May 2, 2009; 30(10): 1229 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
C. P. Dahl, L. Gullestad, B. Fevang, A. M. Holm, L. Landro, L. E. Vinge, A. E. Fiane, W. J. Sandberg, K. Otterdal, S. S. Froland, et al.
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
Eur J Heart Fail, April 1, 2008; 10(4): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Yndestad, L. E. Vinge, R. Bjornerheim, T. Ueland, J. E. Wang, S. S. Froland, H. Attramadal, P. Aukrust, and E. Oie
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Eur J Heart Fail, December 1, 2006; 8(8): 790 - 796.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Yndestad, T. Ueland, E. Oie, G. Florholmen, B. Halvorsen, H. Attramadal, S. Simonsen, S. S. Froland, L. Gullestad, G. Christensen, et al.
Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling
Circulation, March 23, 2004; 109(11): 1379 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Parker and J. J. Thiessen
Increased endothelin-1 production in patients with chronic heart failure
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1141 - H1145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Motte, R. van Beneden, J. Mottet, B. Rondelet, M. Mathieu, X. Havaux, P. Lause, C. Clercx, J.-M. Ketelslegers, R. Naeije, et al.
Early activation of cardiac and renal endothelin systems in experimental heart failure
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2482 - H2491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Katwa
Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1132 - H1139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. E. Vinge, E. Oie, Y. Andersson, H. K. Grogaard, G. O. Andersen, and H. Attramadal
Myocardial distribution and regulation of GRK and beta -arrestin isoforms in congestive heart failure in rats
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2490 - H2499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Loennechen, A. Stoylen, V. Beisvag, U. Wisloff, and O. Ellingsen
Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2902 - H2910.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Zolk and M. Bohm
The role of the cardiac endothelin system in heart failure
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 758 - 760.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Oie, R. Bjornerheim, O. P. F. Clausen, and H. Attramadal
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2115 - H2123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kjekshus, O. A. Smiseth, R. Klinge, E. Oie, M. E. Hystad, and H. Attramadal
Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF
Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1299 - H1310.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Oie, L. E. Vinge, A. Yndestad, C. Sandberg, H. K. Grogaard, and H. Attramadal
Induction of a Myocardial Adrenomedullin Signaling System During Ischemic Heart Failure in Rats
Circulation, February 1, 2000; 101(4): 415 - 422.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. Zolk, J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm
Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure
Circulation, April 27, 1999; 99(16): 2118 - 2123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Oie, R. Bjonerheim, H. K. Grogaard, H. Kongshaug, O. A. Smiseth, and H. Attramadal
ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H868 - H877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online